Showing results (61-70 of 141) with videos related to
Sort By:
Pageof 15
British Journal of Clinical Pharmacology|January 6, 2012
Acetylator phenotype and the clinical pharmacology of slow-release procainamideW Campbell, W J Tilstone, D H Lawson, et al.Atherosclerosis|March 1, 1978
Regulation of cholesterol synthesis in the hyperlipoproteinaemias. Polymorphonuclear leucocyte abnormality specific to familial type II hypercholesterolaemiaW F Bremner, J L Third, B Clark, et al.The New England Journal of Medicine|May 29, 1980
Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolismJ Shepherd, C J Packard, S Bicker, et al.Journal of Electrocardiology|April 1, 1993
Normal limits of derived vectorcardiogram in ChineseT F Yang, C Y Chen, B N Chiang, et al.Circulation|February 1, 1981
Comparative evaluation of the IBM (12-lead) and Royal Infirmary (orthogonal three-lead) ECG computer programsP W Macfarlane, D I Melville, M R Horton, et al.International Journal of Sport Nutrition|September 1, 1993
Failure of commercial oral amino acid supplements to increase serum growth hormone concentrations in male body-buildersM I Lambert, J A Hefer, R P Millar, et al.Journal of Electrocardiology|January 1, 1994
Smoothing techniques for improving the repeatability of the automated diagnosis of inferior myocardial infarctionS C McLaughlin, T C Aitchison, T F Yang, et al.British Journal of Pharmacology|May 1, 1974
The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in manW S Hillis, I Hutton, T D Lawrie, et al.British Journal of Clinical Pharmacology|October 1, 1977
Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart diseaseI Hutton, W S Hillis, C E Langhan, et al.Postgraduate Medical Journal|January 1, 1975
The prevalence of hyperlipoproteinaemia in vascular diseaseT D Lawrie, A R Lorimer, D Ballantyne, et al.Pageof 15